Notting Hill Genesis Publication of a Prospectus: GBP2bn Note Programme (0327Z)

TIDM85FA

RNS Number : 0327Z

Notting Hill Genesis

18 May 2021

Publication of Programme Admission Particulars

Notting Hill Genesis

18 May 2021

The following programme admission particulars (the Programme Admission Particulars) have been approved by the London Stock Exchange and are available for viewing:

Programme Admission Particulars dated 18 May 2021 relating to the GBP2,000,000,000 Secured Note Programme of Notting Hill Genesis

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/0327Z_1-2021-5-18.pdf

For further information, please contact:

 
 Paul Phillips                      Andrew Sugden 
  Chief Financial Officer            Corporate Finance Director 
  Notting Hill Genesis               Notting Hill Genesis 
  Bruce Kenrick House                Bruce Kenrick House 
  2 Killick Street                   2 Killick Street 
  London N1 9FL                      London N1 9FL 
                                     Telephone: [phone] 
  Telephone: [phone]           Email: [e-mail] 
  Email: [e-mail] 
 

DISCLAIMER -- INTENDED ADDRESSEES

Please note that the information contained in the Programme Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Programme Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Programme Admission Particulars is not addressed. Prior to relying on the information contained in the Programme Admission Particulars you must ascertain from the Programme Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PDIGPUUPAUPGGWR

(END) Dow Jones Newswires

May 18, 2021 09:40 ET (13:40 GMT)